Prognostic significance of peripheral blood S100A12, S100A8, and S100A9 concentrations in idiopathic pulmonary fibrosis

被引:1
|
作者
Ding, Dongyan [1 ]
Luan, Rumei [1 ]
Xue, Qianfei
Yang, Junling [1 ,2 ,3 ]
机构
[1] Second Hosp Jilin Univ, Dept Resp Med, Changchun, Peoples R China
[2] Univ Hosp Jilin Univ, Dept Resp Med, Changchun, Peoples R China
[3] Second Hosp Jilin Univ, 218 Ziqiang St, Changchun 130041, Jilin, Peoples R China
关键词
idiopathic pulmonary fibrosis (IPF); S100A12; S100A8; S100A9; Calgranulin; PROTEINS;
D O I
10.1016/j.cyto.2023.156387
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: S100A12, S100A8, and S100A9 are inflammatory disease biomarkers whose functional significance in idiopathic pulmonary fibrosis (IPF) remains unclear. We evaluated the significance of S100A12, S100A8, and S100A9 levels in IPF development and prognosis.Methods: The dataset was collected from the Gene Expression Omnibus (GEO) database and differentially expressed genes were screened using GEO2R. We conducted a retrospective study of 106 patients with IPF to explore the relationships between different biomarkers and poor outcomes. Pearson's correlation coefficient, Kaplan-Meier, Cox regression, and functional enrichment analyses were used to evaluate relationships between these biomarkers' levels and clinical parameters or prognosis.Results: Serum levels of S100A12, S100A8, and S100A9 were significantly elevated in patients with IPF. The two most significant co-expression genes of S100A12 were S100A8 and S100A9. Patients with levels of S100A12 (median 231.21 ng/mL), S100A9 (median 57.09 ng/mL) or S100A8 (median 52.20 ng/mL), as well as combined elevated S100A12, S100A9, and S100A8 levels, exhibited shorter progression-free survival and overall survival. Serum S100A12 and S100A8, S100A12 and S100A9, S100A9 and S100A8 concentrations also displayed a strong positive correlation (r(s)(2) = 0.4558, r(s)(2) = 0.4558, r(s)(2) = 0.6373; P < 0.001). S100A12 and S100A8/9 concentrations were independent of FVC%, DLCO%, and other clinical parameters (age, laboratory test data, and smoking habit). Finally, in multivariate analysis, the serum levels of S100A12, S100A8, and S100A9 were significant prognostic factors (hazard ratio 1.002, P = 0.032, hazard ratio 1.039, P = 0.001, and hazard ratio 1.048, P = 0.003).Conclusions: S100A12, S100A8, and S100A9 are promising circulating biomarkers that may aid in determining IPF patient prognosis. Multicenter clinical trials are needed to confirm their clinical value.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] S100A8, S100A9 and S100A12 proteins in rheumatoid arthritis
    Baillet, A.
    REVUE DE MEDECINE INTERNE, 2010, 31 (06): : 458 - 461
  • [2] Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosis
    Tanaka, Kazuki
    Enomoto, Noriyuki
    Hozumi, Hironao
    Isayama, Takuya
    Naoi, Hyogo
    Aono, Yuya
    Katsumata, Mineo
    Yasui, Hideki
    Karayama, Masato
    Suzuki, Yuzo
    Furuhashi, Kazuki
    Fujisawa, Tomoyuki
    Inui, Naoki
    Nakamura, Yutaro
    Suda, Takafumi
    RESPIRATORY INVESTIGATION, 2021, 59 (06) : 827 - 836
  • [3] Roles of S100A8, S100A9 and S100A12 in infection, inflammation and immunity
    Xia, Pengpeng
    Ji, Xingduo
    Yan, Li
    Lian, Siqi
    Chen, Ziyue
    Luo, Yi
    IMMUNOLOGY, 2024, 171 (03) : 365 - 376
  • [4] Increased plasma levels of S100A8, S100A9, and S100A12 in chronic spontaneous urticaria
    Zhou, Qjong-Yan
    Lin, Wei
    Zhu, Xiao-Xia
    Xu, Su-Ling
    Ying, Meng-Xia
    Shi, Lei
    Lin, Bing-Jiang
    INDIAN JOURNAL OF DERMATOLOGY, 2019, 64 (06) : 441 - 446
  • [5] Significance of calgranulins (S100A8, S100A9 and S100A12), ferritin and toll-like receptor 4 in juvenile idiopathic arthritis children
    Al-Bassam, Wasan W.
    Ad'hiah, Ali H.
    Mayouf, Khadier Z.
    EGYPTIAN RHEUMATOLOGIST, 2020, 42 (02): : 147 - 152
  • [6] Serum S100A8/S100A9 and S100A12 As a Marker Of Disease Activity In Giant Cell Arteritis
    Springer, Jason
    Holzinger, Dirk
    Hoffman, Gary S.
    Monach, Paul A.
    Hamilton, Thomas
    Langford, Carol A.
    Foell, Dirk
    Cuthbertson, David
    O'Rourke, Colin
    Carette, Simon
    Khalidi, Nader A.
    McAlear, Carol
    Pagnoux, Christian
    Seo, Philip
    Warrington, Kenneth J.
    Ytterberg, Steven R.
    Vogl, Thomas
    Merkel, Peter A.
    Roth, Johannes
    Hajj-Ali, Rula
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S706 - S706
  • [7] S100A8 and S100A9 in Cancer
    Chen, Yu
    Ouyang, Yuzhen
    Li, Zhixin
    Wang, Xiufang
    Ma, Jian
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (03):
  • [8] Secretion of S100A8, S100A9, and S100A12 by Neutrophils Involves Reactive Oxygen Species and Potassium Efflux
    Tardif, Melanie R.
    Chapeton-Montes, Julie Andrea
    Posvandzic, Alma
    Page, Nathalie
    Gilbert, Caroline
    Tessier, Philippe A.
    JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [9] Chemotactic activity of S100A8 and S100A9
    Roth, J
    Vogl, T
    Sunderkötter, C
    Sorg, C
    JOURNAL OF IMMUNOLOGY, 2003, 171 (11): : 5651 - 5651
  • [10] S100A8 and S100A9 in experimental osteoarthritis
    Zreiqat, Hala
    Belluoccio, Daniele
    Smith, Margaret M.
    Wilson, Richard
    Rowley, Lynn A.
    Jones, Katie
    Ramaswamy, Yogambha
    Vogl, Thomas
    Roth, Johannes
    Bateman, John F.
    Little, Christopher B.
    ARTHRITIS RESEARCH & THERAPY, 2010, 12 (01)